Simple and eco-friendly biodegradable hydrotropes-assisted spectrophotometric experiments have been designed and validated to quantify ranolazine hydrochloride (RAN.HCl) in extended-release tablets. The citric acid and sodium citrate are employed as hydrotropes, serving as promising alternatives to polar organic solvents. The development of rapid and specific spectrophotometric experiments aimed at enhancing the spectral absorption of RAN.HCl. The spectrophotometric experiments are D0 and D0 AUC, in which the highest peak absorbance was observed at 270.50 nm, with an AUC ranging from 265.00 to 275.50 nm. Moreover, spectral analysis of D1 and D2 were conducted with peak amplitudes recorded at 280.00 nm and 274.40 nm, respectively. The AUC in the wavelength ranges 275.00-287.00 nm for D1, and 265.00-279.50 nm for D2 were implemented to quantify RAN.HCl confirms no interference from the common additives incorporated into the marketed preparation. The optimized experiments disclosed a linear relationship in the 0.02-0.16 mg/mL concentration range. The accuracy was performed at 50-150 %, revealing an overall average recovery of 100.02 %. The lowest limits of RAN.HCl that could be accurately detected and quantified were 0.0016 and 0.0049, 0.0018 and 0.0055, 0.0058 and 0.0176, 0.0024 and 0.0075, 0.0074 and 0.0224, 0.0021 and 0.0064 mg/mL, respectively, across these investigations. Statistical analysis revealed no significant differences between the outcomes of the present investigation and those documented in literature reports, based on the t- and F-values at p = 0.05, which were below the theoretical values of 2.2622, 2.3646, 6.26, and 19.20, respectively.
Keywords: Anti-ischemic; Eco-friendly hydrotropes; Ranolazine hydrochloride; Spectroscopy; Sustainable chemistry.
Copyright © 2024 Elsevier B.V. All rights reserved.